Invesco Pharmaceuticals ETF
PJP
85 hedge funds and large institutions have $81.2M invested in Invesco Pharmaceuticals ETF in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 31 reducing their positions, and 21 closing their positions.
14.91% more ownership
Funds ownership: 0% → 14.91% (+15%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $85.6M → $81.2M (-$4.4M)
11% less funds holding
Funds holding: 96 → 85 (-11)
52% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 21
71% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RFA
Reilly Financial Advisors
La Mesa,
California
|
+$1.76M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$700K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$608K |
| 4 |
FWM
Focused Wealth Management
Newburgh,
New York
|
+$582K |
| 5 |
MIH
Madison Investment Holdings
Madison,
Wisconsin
|
+$555K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$4.19M |
| 2 |
FSA
Financial Sense Advisors
San Diego,
California
|
-$4.09M |
| 3 |
Morgan Stanley
New York
|
-$1.6M |
| 4 |
Jane Street
New York
|
-$811K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$803K |
PJP Hedge Fund Activity: Q2 2018 in Review
85 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q2 2018, worth a combined $81.2M — down 5.1% from $85.6M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of PJP and 10 opened new positions — a net loss of 11 holders — while 31 trimmed existing stakes and 9 added.
The largest buyer was Reilly Financial Advisors, opening a new position worth an estimated $1.76M. The largest seller was Bank of America, cutting an estimated $4.19M.
- 85 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q2 2018, down from 96 in Q1 2018.
- Funds reported $81.2M of Invesco Pharmaceuticals ETF stock for Q2 2018, down 5.1% quarter-over-quarter.
- 10 funds opened new Invesco Pharmaceuticals ETF positions in Q2 2018 and 21 closed out, a net change of -11 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q2 2018 was Reilly Financial Advisors, an estimated $1.76M added.
- The largest Invesco Pharmaceuticals ETF seller in Q2 2018 was Bank of America, an estimated $4.19M sold.
Based on aggregated 13F filings for Q2 2018.